Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

3.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.2K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

380
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
380
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

78
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
78
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

4.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.5K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

138
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
138

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same authorSame Topic

Designs of the clinical trials aiming at evaluating cell and gene therapy products: A critical appraisal from a literature review.

Molecular therapy. Advances·2026
Same author

Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

Science translational medicine·2026
Same author

Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML.

Blood cancer journal·2026
Same author

Persistent <i>BCR::ABL1</i>-positive preleukemic stem cells drive late clonal evolution in Philadelphia chromosome-positive ALL.

HemaSphere·2026
Same author

Information borrowing in phase II randomized dose-ranging clinical trials in oncology.

BMC medical research methodology·2026
Same author

Ultra-high-sensitivity next-generation sequencing-based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort.

Blood cancer journal·2026

相关实验视频

Updated: Jul 10, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K

使用基于剂量反应模型的贝叶斯排名方法对药物组合进行查.

Luana Boumendil1, Morgane Fontaine2, Vincent Lévy1,3

  • 1Université Paris Cité, INSERM U1153, Team ECSTRRA, Paris, France.

Biometrical journal. Biometrische Zeitschrift
|November 20, 2023
PubMed
概括

这项研究引入了一种新的基于等级的选方法,用于识别有效的药物组合,即使生物资源有限. 该方法有效地排名潜在的癌症治疗方法,解决剂量反应分析中的挑战.

关键词:
贝叶斯模型是贝叶斯模型.剂量-反应模型.药物查对药物进行查.排名 排名 排名 排名 排名

更多相关视频

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.2K

相关实验视频

Last Updated: Jul 10, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.2K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 生物统计学 生物统计学
  • 在瘤学瘤学.

背景情况:

  • 药物组合对于治疗癌症等复杂疾病至关重要,有可能减少药物耐药性和解决瘤异质性.
  • 鉴定最佳药物组合是具有挑战性的,因为高成本,有限的生物材料,和患者的变化.
  • 现有的方法在选众多药物组合时,因资源限制而扎.

研究的目的:

  • 开发一种基于等级的选方法,用于在有限的生物资源条件下识别强效药物组合.
  • 建立一个强大的方法来对药物组合进行排名,使用层次化的贝叶斯模型和活动指标.
  • 解决药物组合查中成本和样本限制的挑战.

主要方法:

  • 利用一个层次化的贝叶斯四参数逻辑逻辑 (4PLL) 模型来估计剂量反应曲线.
  • 采用了适合有限的生物样本的节的实验设计.
  • 计算活动排名指标,包括剂量反应曲线下的面积和Bliss协同得分.
  • 整合后排位分布和积累排位曲线下的面积,用于全面排名.

主要成果:

  • 拟议的基于等级的选方法在模拟中显示出良好的操作特性.
  • 该方法有效地在各种场景中确定了有前途的治疗方法,包括有限的样本大小和患者间的变化.
  • 该方法成功地使用来自急性髓性白血病组合查实验的真实数据来说明.

结论:

  • 开发的基于等级的方法提供了一个有效的策略,用于药物组合查有限的资源.
  • 这种方法提供了一种可靠的方式来对潜在的药物组合进行排名,有助于发现新的癌症治疗方法.
  • 这种方法适用于各种生物材料和患者数据的限制,如急性髓性白血病研究所示.